1. Home
  2. IMKTA vs NUVB Comparison

IMKTA vs NUVB Comparison

Compare IMKTA & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

HOLD

Current Price

$88.99

Market Cap

1.7B

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.29

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMKTA
NUVB
Founded
1963
2018
Country
United States
United States
Employees
N/A
298
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
IMKTA
NUVB
Price
$88.99
$4.29
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$11.38
AVG Volume (30 Days)
104.4K
3.1M
Earning Date
05-11-2026
05-04-2026
Dividend Yield
0.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,334,032,609.00
N/A
Revenue This Year
N/A
$203.82
Revenue Next Year
N/A
$58.18
P/E Ratio
$15.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.09
$1.57
52 Week High
$95.62
$9.75

Technical Indicators

Market Signals
Indicator
IMKTA
NUVB
Relative Strength Index (RSI) 47.98 36.00
Support Level $86.93 $4.06
Resistance Level $89.76 $5.42
Average True Range (ATR) 2.30 0.27
MACD -0.40 -0.03
Stochastic Oscillator 24.21 6.67

Price Performance

Historical Comparison
IMKTA
NUVB

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: